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Abstract
Background: Bacterial vaginosis (BV) is a common condition, although its aetiology remains unexplained. The aim
of this study was to analyse the composition of vaginal microbiota in women from Greenland to provide a
quantitative description and improve the understanding of BV.
Methods: Self-collected vaginal smears and swabs were obtained from 177 women. The vaginal smears were
graded for BV according to Nugent’s criteria. The vaginal swab samples were analysed by 19 quantitative PCRs
(qPCRs) for selected vaginal bacteria and by PCR for four sexually transmitted infections (STIs).
Results: STIs were common: Mycoplasma genitalium 12%, Chlamydia trachomatis 7%, Neisseria gonorrhoeae 1%, and
Trichomonas vaginalis 0.5%. BV was found in 45% of women, but was not associated with individual STIs. Seven of
the 19 vaginal bacteria (Atopobium vaginae, Prevotella spp., Gardnerella vaginalis, BVAB2, Eggerthella-like bacterium,
Leptotrichia amnionii, and Megasphaera type 1) had areas under the receiver operating characteristic (ROC) curve > 85%,
suggesting they are good predictors of BV according to Nugent. Prevotella spp. had the highest odds ratio for BV
(OR 437; 95% CI 82–2779) in univariate analysis considering only specimens with a bacterial load above the threshold
determined by ROC curve analysis as positive, as well as the highest adjusted odds ratio in multivariate logistic
regression analysis (OR 4.4; 95% CI 1.4-13.5). BV could be subdivided into clusters dominated by a single or a few
species together.
Conclusions: BV by Nugent score was highly prevalent. Two of seven key species (Prevotella spp. and A. vaginae)
remained significantly associated with BV in a multivariate model after adjusting for other bacterial species. G. vaginalis
and Prevotella spp. defined the majority of BV clusters.
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Background
The human vaginal flora has an impact on the health of
a woman and, if she is pregnant, on her foetus and new-
born child. It is generally accepted that a healthy vaginal
microbiome is dominated by Lactobacillus spp., while
the replacement of these bacteria with facultative and strict
anaerobes, such as Gardnerella vaginalis, Prevotella spp.,
Peptostreptoccocus spp., Mobiluncus spp., and a wide range
of fastidious and uncultured bacteria leads to a switch from
normal vaginal microbiota to bacterial vaginosis (BV) [1].
BV is the predominant cause of genital complaints in
women of childbearing age worldwide [2]. About one in
five adult women will have a BV episode annually; however,
the condition is symptomatic in only half of women with
BV. BV is associated with preterm birth and an increased
risk of spontaneous miscarriage, increased risk of acquiring
sexually transmitted infections (STIs), particularly genital
herpes and HIV, as well as with post-abortion endometritis
and post-hysterectomy vaginal cuff infection [1].
BV is commonly diagnosed clinically using Amsel’s cri-
teria [3], which consist of four characteristics, including
a homogeneous, white vaginal discharge; fishy odour of
the vaginal discharge before or after addition of 10% po-
tassium hydroxide; a pH of the vaginal fluid higher than
4.5; and the presence of clue-cells (squamous epithelial
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cells covered with adherent bacteria). At least three of
the criteria must be present to diagnose BV. In research
settings, a BV diagnosis is usually determined by micros-
copy of Gram-stained vaginal secretions, and the Nugent
score is considered the gold standard [4]. More recently,
an alternative scoring of vaginal smears, the Claeys’ criteria,
was described [5], aiming to improve the discrimination
between various morphotypes not accounted for in the
Nugent score. The Claeys score is based on Ison-Hay’s cri-
teria [6] with a more detailed evaluation of normal flora.
Using the Claeys score, pregnant women with BV-like flora
(grade 2 or 3), grade 1-like (small, short, irregularly shaped
Gram positive rods) or 1-PMN (smears with over 50 poly-
morphonuclear leukocytes [PMN]/high power microscopy
field in the absence of Candida) were shown to be at high
risk for adverse pregnancy outcomes [7].
Despite significant research efforts in this area, no
aetiological factors for BV have been identified [8]. Strik-
ing differences among populations have been observed;
e.g., black women have significantly higher rates of BV
than Caucasian women [9], and vaginal pH varies among
different ethnic groups: Hispanic and black women have
a higher average vaginal pH compared to Asians and
Caucasians [10]. On the other hand, it has been sug-
gested that a high Nugent score in asymptomatic women
should be considered a separate group of normal flora
(community group IV) [10]. Thus, the vaginal micro-
biota appears to depend partly on the ethnicity of the
host and, consequently, of genetic and/or geographic
and social factors.
It has been debated whether BV is sexually transmit-
ted, as the carriage rates of G. vaginalis, a key bacterium
in BV [11], were significantly higher in heterosexual men
than among men who have sex with men [12], and BV
was not found in sexually inexperienced women [13].
Many epidemiological features of BV are the same as
those of STIs [14], although treatment of the male sexual
partner does not decrease the rate of BV recurrence.
However, BV may be considered a sexually enhanced
disease, with the frequency of unprotected intercourse
being a major predisposing factor [15].
Although the prevalence of STIs is high in the
Greenlandic population [16,17], there are few publica-
tions describing the vaginal microbiota of women from
Greenland. One study found a BV prevalence of 38% in
Nuuk using Amsel’s criteria [18].
Microscopy of Gram-stained vaginal smears is consid-
ered the gold standard for diagnosing BV, but this ap-
proach does not provide detailed information about the
vaginal microbiome, whereas species-specific real-time
PCR can identify and quantify each bacterium. In this
work, we present a cross-sectional, observational study
on a cohort of women from Greenland aimed at present-
ing a detailed quantitative characterisation of the vaginal
bacteria composition using microscopy and 19 quantitative
real-time PCRs specific for bacteria that have been com-
monly reported as part of the human vaginal microbiome.
We used threshold quantification to optimise the molecular
techniques by using receiver operating characteristic (ROC)
curve analysis to objectively define cut-off points for the
diagnostic tests. We refer to this approach as quantitative
detection, in which samples above the cut-off are consid-
ered positive, while samples with a bacterial load below the
threshold are scored as negative. In qualitative detection,
the samples are considered positive if DNA is detected
(presence vs. absence). The diagnostic performance for BV
detection was evaluated by both qualitative and quantitative
detection using Nugent’s score as the reference.
Methods
Study population and specimens
A total of 196 women were included in “Inuulluataarneq”
(the Greenland Sexual Health Project), a project aimed at
quantifying the prevalence of STIs in Greenland and to
identify individual, familial, social, cultural and envi-
ronmental factors contributing to Greenland’s high STI
rates [19,20]. The two inclusion periods were from July to
October 2008 in Nuuk and November 2009 in Sisimiut
during “Health Week.” Women were recruited from the
general population via the population registry and by direct
contact via telephone calls and advertising in local media,
as previously described [17].
Ethics statement
The project was approved by the Greenlandic ethics
board, under the auspices of the Commission for Research
in Greenland (KVUG), and the University of Toronto
Research Ethics Board (21108 and 22173, September
2007 and June/October 2009, respectively). Study subjects
provided written informed consent before participating in
the study.
Sample collection
Self-obtained vaginal swabs, vaginal smears, and first-
void urine specimens were collected after an interviewer-
administered structured survey. The women were given a
pictorial instruction sheet on how to self-collect vaginal
swabs by inserting a flocked swab (Copan, Brescia, Italy)
approximately five cm into the vagina, using the breaking
score as a guide to ensure that samples were collected
properly. One swab was rolled onto a pre-labelled slide,
which was left to air-dry. A second flocked swab was
similarly obtained and placed in UTM transport medium
(Universal Transport Medium, Copan, Brescia, Italy). First-
void urine was collected in GeneLock nucleic acid stabilisa-
tion medium (Sierra Molecular Corp., Sonora, CA, USA).
The samples were stored in a refrigerator at 5°C until they
were shipped at weekly intervals from Nuuk at ambient
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temperature and from Sisimiut in one bulk shipment
at the end of Health Week to Statens Serum Institut in
Denmark.
Microscopy
BV was diagnosed by microscopy of Gram-stained smears
and classified by Nugent score [4]. All slides were scored
by the same investigator (RD), who was blinded to any
clinical or laboratory results.
Inflammation was graded in at least 5 microscopic
fields as 0 (no PMN), + (< 10 PMN/ high power field
[hpf]), ++ (10–50 PMN/hpf ), or +++ (>50 PMN/hpf ).
A PMN count >10/hpf (i.e., ++ and +++) was consid-
ered abnormal [7]. The presence of Candida cells and
hyphae was graded as: absence, few cells/hyphae (≤3 on
average in at least 10 hpf) and many cells/hyphae (> 3 on
average/hpf).
DNA extraction and positive controls for PCR assays
Cells were released from vaginal swab specimens in
UTM by thorough vortexing. Cells from 950 μl of the
UTM were pelleted by centrifugation for 15 minutes at
30,000 × g. The supernatant was removed, and the pellet
was vortexed for 60 seconds with 150 μl of 20% Chelex
100 slurry (BioRad, Hercules, CA, USA) in TE buffer
(10 mM Tris–HCl [pH 8.0] and 1 mM EDTA). The sam-
ples were heated at 95°C for 10 minutes, and condensa-
tion droplets were collected by a brief centrifugation
[21]. Urine specimens were treated similarly.
Positive controls and specificity controls for the PCRs
were obtained by DNA extraction from culture collection
strains of Atopobium vaginae (CCUG 38953T), Sneathia
sanguinegenes (CCUG 41628T), Leptotrichia amnionii
(DSM 16630), Mobiluncus curtisii (CCUG 21018T),
M. mulieris (CCUG 20071T), Lactobacillus iners (CCUG
28746T), L. crispatus (CCUG 30722), L. gasseri (DSM
14869), L. jensenii (CCUG 21961), Gardnerella vaginalis
(ATCC 3717T), Mycoplasma hominis (ATCC 15488), Urea-
plasma parvum (ATCC 27815 T), U. urealyticum (ATCC
27618 T), Finegoldia magna (DSM 20470T), Pepto-
streptococcus anaerobius (CCUG 7835), and Veillonella
montpellierensis (CCUG 48299), and from clinical iso-
lates of Prevotella oris, P. bivia (2 different strains),
P. nigrescens (2 different strains), P. buccae (2 different
strains), P. loeschii, and P. intermedia identified by bio-
chemical properties and MALDI-TOF and/or sequencing
of 16S rRNA genes. DNA from cultured bacteria was
extracted using the standard protocol with the QIAGEN
Blood and Tissue kit (Qiagen, Hilden, Germany) except
for Lactobacillus spp., for which the cells were suspended
in 400 μl lysis buffer (20 mM Tris–HCl; 2 mM EDTA;
1.2% vol/vol Triton X-100) as previously published [22],
6 mg of lysozyme dissolved in 15 μl TE buffer was added
and samples were incubated for 30 minutes at 37°C.
Subsequently, the standard QIAamp DNA mini kit proto-
col was followed.
For uncultured bacteria BVAB 1, 2, 3, TM7, Mega-
sphaera type 1 and 2, and Eggerthella-like bacterium, PCR
products from a positive clinical sample were used as
positive controls. The PCR products were gel-purified
with a QIAquick Gel Extraction Kit (Qiagen) and DNA
sequenced for verification.
Genomic and amplified DNA for positive controls were
quantified fluorometrically with a Qubit fluorometer, using
Quant-iT™ dsDNA HS Assay Kit (Life Technologies Corp.,
Paisly, UK). Standard curves for quantitative PCRs were
generated using 10-fold dilutions ranging from 1 genome
equivalent (geq)/μl to 107 geq/μl in TE buffer containing
1 μg/ml of calf thymus DNA (D-8661; Sigma-Aldrich).
PCR analyses
Vaginal swabs and FVU were examined by PCR for Myco-
plasma genitalium, Chlamydia trachomatis, Neisseria
gonorrhoeae, and Trichomonas vaginalis as previously
described [17]. M. genitalium was detected by real-time
PCR targeting the MgPa-gene [21] and confirmed by con-
ventional PCR for the 16S rRNA gene [23]. C. trachomatis
was detected by real-time PCR targeting the 16S rRNA
gene [24] and all positive results were confirmed by real-
time PCR for the C. trachomatis cryptic plasmid [24].
There was no evidence that the new variant of C. tracho-
matis was present in these samples [17]. N. gonorrhoeae
was detected by a porA pseudogene real-time PCR
[25]. T. vaginalis was detected by a conventional PCR
with primers targeting a T. vaginalis specific repeat DNA
fragment [26].
Quantitative PCRs were performed on vaginal swabs
for selected BV associated bacteria, including A. vagi-
nae, S. sanguinegens, L. amnionii, Bacterial Vaginosis-
Associated Bacterium 1, 2, 3 and TM7 (BVAB 1, 2, 3 and
TM7), Megasphaera type 1 and 2, Eggerthella-like bacter-
ium, M. curtisii and M. mulieris, L. iners, G. vaginalis,
M. hominis, U. parvum, U. urealyticum, F. magna, and
Prevotella spp. Primers used for Megasphaera type 1
and Eggerthella-like bacterium as well as primers and
probe for G. vaginalis were previously published by
Fredricks [27,28], and specificity was documented by
amplicon sequencing. For the remaining assays, specificity
was documented by melt-curve analysis and during assay
optimisation by gel-electrophoresis that demonstrated
amplicons of the expected length. Sequencing (Big-Dye
version 3.0, Life Technologies) of selected amplicons was
used to document specificity.
PCR with TaqMan probes (A. vaginae, S. sanguinegens,
L. amnionii, L. iners, M. hominis) was performed in a
50 μl final volume containing 1× PCR Reaction Buffer -
20 mM Tris–HCl pH 8.4, 50 mM KCl – (Life Tech-
nologies); 125 μM (each) of dATP, dCTP and dGTP;
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and 250 μM dUTP; 1 μM forward and reverse primers,
75 nM probe, 5 mM MgCl2, and 2 U Platinum® Taq
DNA polymerase (Life Technologies). For the G. vagi-
nalis TaqMan probe assay, Platinum® Quantitative PCR
SuperMix-UDG (Life Technologies) and the same final
concentrations of primers, probe and MgCl2 as above
were used. U. urealyticum and U. parvum were detected
in a multiplex PCR with 150 nM probes, 1 μM of the
common forward primer and 2 μM of reverse primer for
U. urealyticum and 1 μM of reverse primer for U. parvum;
the other reagents were as previously described. An ABI
7500 Sequence Detection System was used with 96-well
conventional blocks (Life Technologies) with a 95°C,
10 min initial denaturation and 50 cycles of 95°C for 15 s
for denaturation and 60°C for 1 min for annealing and
extension.
SYBR Green assays (BVAB1, BVAB2, BVAB3, BVABTM7,
Megasphaera type 1 and 2, Eggerthella-like bacterium,
M. curtisii, M. mulieris, Prevotella spp., and F. magna)
were performed in a 50 μl final volume with reagents as
described for TaqMan assays, except that the primers
were used at 0.4 μM and MgCl2 concentrations var-
ied between 1.5-3.5 mM, as listed in Additional file 1:
Table S1. SYBR Green (Life Technologies) was used at a
1:5000 dilution. An ABI 7500 instrument was used with
cycling conditions consisting of an initial 10 min denatur-
ation followed by 10 cycles of touch-down PCR with a 1°C
decrement per cycle until reaching the intended annealing
temperature, which was used for the subsequent 30 cycles
followed by a melt-curve analysis. Cycling conditions for
each of the bacterial species are listed in Additional file 1:
Table S1.
All results are expressed as the number of 16S rRNA
gene copies/ml UTM.
All vaginal swab samples were checked for inhibition
in the diagnostic PCRs detecting STI pathogens. How-
ever, to estimate the robustness and influence of non-
target DNA on the SYBR Green assays (BVAB1, 2, 3,
TM7, Eggerthella-like bacterium, Megasphaera type 1
and 2, M. curtisii, M. mulieris), the standard curves were
evaluated with and without the presence of negative clin-
ical samples.
PCR method validation
Primers for A. vaginae, L. amnionii, S. sanguinegens,
and F. magna were designed for the present study.
The specificity of the primer sequences was exam-
ined by BLAST search of GenBank sequences. The
TaqMan assays were challenged with 105 genome equiva-
lents (geq) of A. vaginae, L. amnionii, and S. sanguinegens.
For the F. magna PCR, seven amplicons from random
clinical specimens were sequenced and had 100% hom-
ology to the GenBank sequence; furthermore, puri-
fied DNA from the related species Peptostreptococcus
anaerobius and Veillonella montpellierensis did not cross-
react in the assay.
For BVAB1, BVAB2, Megasphaera type 2, BVAB TM7,
M. curtisii, and M. mulieris, the published primers were
slightly modified at the 5′-end to adjust the annealing
temperature (see Additional file 1: Table S1). However,
the 3′-end remained unchanged, and therefore the spec-
ificities of the primers as described in the original publi-
cations were preserved [27,28].
For BVAB3, a combination of forward and reverse
primers published in two different studies were used and
modified at the 5′-end (see Additional file 1: Table S1).
A BLAST search showed a 100% match with the BVAB3
16S rRNA gene sequence and lacked any other signifi-
cant matches. The sequencing of amplicons from a ran-
dom clinical specimen revealed a 100% match with the
published sequence, and the melt-curve analysis showed
distinct peaks.
M. curtisii DNA did not cross react in the M. mulieris
real-time assay and vice-versa.
For the L. iners assay, the forward and reverse primers
were combined from assays described in two previous pub-
lications [22,29], modified at the 5′-end (see Additional
file 1: Table S1) and used with a probe designed for the
present study. Cross-reactions with L. crispatus, L. gasseri,
and L. jensenii DNA were studied by challenging the assays
with 105 geq of each species.
The Prevotella spp. primers were previously published
and slightly modified at the 5′-end (see Additional file 1:
Table S1). The PCR primers were genus-wide and,
according to a BLAST search, matched perfectly to 20 dif-
ferent Prevotella species: P. timonensis, P. bivia, P. melani-
nogenica, P. buccae, P. histicola, P. disiens, P. buccalis,
P. scopos, P. fusca, P. copri, P. salivae, P. oris, P. veroralis,
P. paludivivens, P. pallens, P. oulorum, P. nigrescens,
P. maculosa, P. corporis, and P. intermedia. Dilutions
ranging from 1 geq/5 μl to 104 geq/5 μl were prepared
from clinical isolates of P. oris, P. bivia (2 different strains),
P. nigrescens (2 different strains), P. buccae (2 different
strains), P. loeschii, and P. intermedia strains and used as
templates in the Prevotella spp. assay to determine sensitiv-
ity for different strains.
Precautions to avoid PCR product carryover
All pre-PCR manipulations were performed in a labora-
tory accredited according to the ISO 17025 standard to
perform diagnostic PCR. Strict physical separation between
PCR setup and analysis laboratories was maintained, and
separate staff were dedicated to pre- and post-PCR work.
All pre-PCR steps were carried out in laminar flow hoods,
and sterile filter tips were used in all sample manipulations.
All surfaces in the PCR setup laboratory were exposed to
UV light between sessions and regularly wiped with a solu-
tion containing hypochlorite to destroy contaminating
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DNA [30]. At least two negative controls, including a
mock-extracted sample, were included in each PCR run.
All PCRs were performed with dUTP instead of dTTP to
allow enzymatic prevention of PCR product carryover with
uracil-N-glycosylase. Uracil-N-glycosylase was not used,
however, because no carryover was observed.
Determination of cut-off for optimal BV prediction
ROC curve analysis was used to determine the optimal
bacterial load threshold in geq/ml UTM in women with
and without BV, weighing sensitivity and specificity
equally. For the calculation of the sensitivity and specifi-
city for BV prediction, the Nugent score was used as the
gold standard, and Grade II (intermediate flora) was ex-
cluded from the evaluation. For all 19 bacterial species,
the sensitivity and specificity before ROC (qualitative de-
tection) was calculated for 79 participants with BV and
73 participants without BV. Bacterial species with an
area under the curve (AUC) > 85%, a value that sug-
gested good discriminatory power, were selected for fur-
ther analysis in a multivariate logistic regression model.
Statistical methods
ROC curve analysis, Fisher’s exact test, and odd-ratios
with confidence intervals as well as kappa statistics were
calculated in StatsDirect version 2.7.8 (StatsDirect Ltd.,
Cheshire, UK).
Logistic regression analysis and Cochran-Armitage
trend tests were performed in SAS version 9.2 (SAS Insti-
tute Inc. Cary, NC, USA). A heat-map was constructed by
normalising the number of 16S rRNA gene copies/ml
UTM (the proportion of gene-copies for an individual spe-
cies to the total sum of gene-copies for all bacteria studied)
and using the Heat map routine in the R program
package version 2.15.0 (The R Foundation for Statistical
Computing). Co-occurrence of bacterial taxa was investi-
gated by calculating Spearman correlation coefficients
using the routine correlation orders in the R program
package. The significance level was 5%, and two-sided re-
sults were used throughout.
Results
Study population
Out of a total of 196 women enrolled in “Inuulluataarneq,”
177 women provided both swabs and suitable smears and
were considered eligible. The women ranged from 15 –
65 years in age, with a median of 24 and mean of 29
(Table 1). Six participants were between 55 and 65 years
old and presumably post-menopausal, but no infor-
mation regarding age of menopause was collected. The
median lifetime number of male sexual partners was
12.5, range 0 – 320 and interquartile range 20. Among
the 168 women who provided information about their life-
time number of female sexual partners, 30 women had
female sexual partners, including 26 who had male part-
ners as well. Twelve women were registered as having no
history of male or female sex partners, of whom four were
diagnosed with BV by Nugent’s classification. The majority
of the women (72%, 117 of 163 who answered the ques-
tion) reported that they would always use a condom with a
new partner they had only known for a few weeks. Partici-
pants were asked whether they had any STI symptoms and
67 (75%) of the 89 women who answered this question de-
clared that they had no symptoms, 15 women said they did
not know and 7 women reported symptoms. Among the
women who reported symptoms, two had STIs and four
had BV. No questions were asked about contraceptive use,
douching or recent antibiotic use. However, douching is
known not to be a common practice in Greenland.




Median (50th percentile) 24 years
Lower quartile (25th percentile) 19
Upper quartile (75th percentile) 37
Inclusion town N1 (%)
Nuuk 83 (47%)
Sisimiut 94 (53%)
BV diagnosis by Nugent score N (%)
Grade I (normal) 73 (41%)
Grade II (intermediate) 25 (14%)
Grade III (BV) 79 (45%)
STIs2 and yeast infection N (%)
Mycoplasma genitalium 22 (12%)
Chlamydia trachomatis 12 (7%)
Neisseria gonorrhoeae 2 (1%)
Trichomonas vaginalis 1 (0.5%)
Yeasts3 14 (8%)
Lifetime number of male sexual partners4
Range 0-320
Median (50th percentile) 12.5
Lower quartile (25th percentile) 5
Upper quartile (75th percentile) 25
Lifetime number of female sexual partners4
Range 0-10
Median (50th percentile) 0
Lower quartile (25th percentile) 0
Upper quartile (75th percentile) 0
1N indicates number of participants.
2Considered positive if specific PCR was found positive in swab, urine or both.
3Either spores, hyphae or both by microscopy.
4Only 168 women gave information.
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As previously described [17], 22 women (12%) were
positive for M. genitalium, 12 (7%) were positive for
C. trachomatis, 2 (1%) for N. gonorrhoeae and one
woman had T. vaginalis (0.5%) in either the vaginal swab
sample or in the first void urine. Three women had a
mixed infection with M. genitalium and C. trachomatis.
PCR methods validation
No cross-reactions were observed in the A. vaginae,
L. amnionii or S. sanguinegens TaqMan assays when chal-
lenged with 105 geq of the other species. Similarly, no cross
reactions with L. crispatus, L. gasseri or L. jensenii DNA
were observed in the L. iners assay.
The sensitivity of the Prevotella spp. assay for various
species was determined to be 1 geq for P. oris, 10 geq
and 100 geq for two strains of P. bivia, 10 geq for
P. nigrescens (two strains), 1 geq for P. buccae (two
strains), and 80 geq for P. intermedia. For P. loeschii, the
sensitivity of the Prevotella spp. assay was much lower
(4x103 geq), as there were several mismatches in the pri-
mer sequence.
The limit of detection for the real-time PCR assays is
shown in Additional file 1: Table S1.
BV microscopy results
The BV prevalence was 45% as determined by Nugent’s
classification, and 73 participants (41%) had a normal
score, while 25 (14%) had an intermediate score (Table 1).
Most women (80%) had normal leucocyte counts, i.e.,
below 10 PMN/hpf, while 35 women (20%) had more
than 10 PMN/hpf, suggesting inflammation. Among
the women with high leucocyte counts, 11 (31%) were
positive for STIs, and 2 had vulvovaginal candidiasis. Four-
teen women (8%) carried yeasts, as determined by micros-
copy (Table 1).
Determination of cut-off for optimal BV prediction
Because the sensitivity and specificity of BV prediction
by qualitative detection (presence versus absence) were
quite low for all species (Table 2), ROC curve analysis was
used to determine the optimal threshold for the bacterial
load (cut-off) for BV prediction. The cut-off or threshold
according to ROC curve analysis is shown for each species
in Table 2. An area under the curve (AUC) of > 85%,
suggesting a good discriminatory power, was found
for A. vaginae (97%), Prevotella spp. (96%), G. vaginalis
(95%), BVAB2 (94%), Eggerthella-like bacterium (91%),
Table 2 Sensitivity and specificity before (qualitative detection1) and after (quantitative detection2) applying ROC
curve analysis
Species Qualitative detection1 Quantitative detection2 AUC
Se (%) 95% CI Sp (%) 95% CI Se (%) 95% CI Sp (%) 95% CI Cut-off/ml Size (%) 95% CI
Atopobium vaginae* 100 95-100 25 15-36 95 88-99 92 83-97 ≥55556 97 95-99
Sneathia sanguinegens 75 64-84 86 76- 93 67 56-77 97 90-100 ≥14127 85 79-90
Leptotrichia amnionii* 86 76-93 59 47- 70 80 69-88 97 90-100 ≥1746 89 83-94
BVAB 1 67 56-77 68 57-79 54 43-66 93 85-98 ≥9841 75 68-82
BVAB 2* 91 83-96 79 68-88 87 78-94 97 90-100 ≥3492 94 90-98
BVAB 3 66 54-76 86 76-93 66 54-76 92 83-97 ≥95 80 74-86
BVAB-TM7 34 24-46 100 95-100 34 24-46 100 95-100 ≥2698 67 62-72
Megasphaera type 1* 86 76-93 59 47-70 81 71-89 99 93-100 ≥41111 88 82-94
Megasphaera type 2 32 22- 43 93 85-98 28 18-39 100 95-100 ≥1111 63 58-69
Eggerthella-like bacterium* 95 88-99 36 25-48 78 68-87 96 88-99 ≥297937 91 86-96
Mobiluncus curtisii 25 16-36 99 93-100 25 16-36 99 93-100 ≥794 62 57-67
Mobiluncus mulieris 20 12-31 93 85- 98 15 8-25 99 93-100 ≥166349 57 52-62
Gardnerella vaginalis* 100 95-100 3 0.3-10 87 78-94 92 83-97 ≥4803175 95 91-98
Mycoplasma hominis 63 52-74 85 75-92 58 47-69 96 88-99 ≥3968 78 71-84
Ureaplasma parvum 51 39-62 49 37- 61 28 18-39 75 64-85 ≥31746 50 42-59
Ureaplasma urealyticum 18 10-28 90 81-96 14 7-24 95 87-98 ≥22381 54 49-59
Finegoldia magna 63 52-74 59 47-70 63 52-74 59 47-70 ≥159 61 52-69
Prevotella spp.* 97 91-100 4 0.8-12 95 88-99 96 88-99 ≥888889 96 92-100
1Presence versus absence as determined by qPCR.
2Presence (≥ cut-off/ml) versus absence (< cut-off/ml) with cut-off determined by ROC curve analysis.
A total of 79 participants with Nugent III and 73 with Nugent I were used for the evaluation. Intermediate flora not included. L. iners is excluded from the table
because it acts as a negative predictor for BV.
*Bacterial species with area under the ROC curve (AUC) > 85%.
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L. amnionii (89%), and Megasphaera type 1 (88%).
The ROC curve for L. iners was concave because this
bacterium was predictive for normal vaginal flora.
A. vaginae had the largest AUC (97%), indicating the
best diagnostic accuracy. A combination of A. vaginae
and Prevotella spp. in quantitative detection had a speci-
ficity of 99% and sensitivity of 90%, while A. vaginae or
Prevotella spp. gave optimal sensitivity (100%) but a spe-
cificity of 89%.
Relationship between PCR results and microscopy
The average number of non-Lactobacillus species de-
tected per participant was 11.7 (range 5–16) for women
with BV, 6.2 (range 3–10) for women with a normal
score, and 8.6 (range 4–15) for women with an inter-
mediate score using qualitative data (presence versus ab-
sence) from the 18 specific assays. For each group, the
difference in diversity was statistically significant com-
pared to any other group.
The percentage of cases in which each qPCR assay
was positive by Nugent score category is presented in
Table 3. A significantly increasing trend in the propor-
tion of positive results in qualitative detection was found
with increasing BV grade for all non-Lactobacillus species
except G. vaginalis, U. parvum, U. urealyticum, and
Prevotella spp., while all non-Lactobacillus species except
U. parvum and U. urealyticum showed a significantly in-
creasing trend in quantitative detection. The bacterial load
of all non-Lactobacillus species increased statistically
significantly with the progression from normal to BV
microbiota for all species studied except U. parvum and
U. urealyticum. The median bacterial loads for all species
were higher for BV than for the normal microbiome except
BVAB TM7, Megasphaera type 2, M. curtisii, M. mulieris,
and U. urealyticum, for which medians for both Nugent I
and III were 0. For U. parvum and L. iners, medians for
Nugent I were higher than those for Nugent III.
Associations between age, lifetime number of male
sexual partners, STIs and BV
The median age was the same (24 years) for women with
Nugent I flora and women with Nugent III (p = 0.8); no
relationship between the lifetime number of male sexual
partners and BV could be found.
No statistically significant relationships between indi-
vidual STIs and BV could be found.
Table 3 Proportion of women in which non-Lactobacillus species were detected
Nugent I (0–3) Nugent II (4–6) Nugent III (7–10) p-values for trend

















N (%) N (%) N (%) N (%) N (%) N (%) p-value p-value
A. vaginae 55 (75) 6 (8) 22 (88) 13 (52) 79 (100) 75 (95) <0.0001 <0.0001
S. sanguinegens 10 (14) 2 (3) 9 (36) 5 (20) 59 (75) 53 (67) <0.0001 <0.0001
L. amnionii 30 (41) 2 (3) 15 (60) 6 (24) 68 (86) 63 (80) <0.0001 <0.0001
BVAB 1 23 (31) 5 (7) 11 (44) 6 (24) 53 (67) 43(54) <0.0001 <0.0001
BVAB 2 15 (21) 2 (3) 10 (40) 8 (32) 72 (91) 69 (87) <0.0001 <0.0001
BVAB 3 10 (14) 6 (8) 11 (44) 9 (36) 52 (66) 52 (66) <0.0001 <0.0001
BVAB-TM7 0 (0) 0 (0) 6 (24) 6 (24) 27 (34) 27 (34) <0.0001 <0.0001
Megasphaera type 1 30 (41) 1 (1) 17 (68) 9 (36) 68 (86) 64 (81) <0.0001 <0.0001
Megasphaera type 2 5 (7) 0 (0) 3 (12) 2 (8) 25 (32) 22 (28) <0.0001 <0.0001
Eggerthella-like bacterium 47 (64) 3 (4) 18 (72) 6 (24) 75 (95) 62 (78) <0.0001 <0.0001
M. curtisii 1 (1) 1 (1) 3 (12) 3 (12) 20 (25) 20 (25) <0.0001 <0.0001
M. mulieris 5 (7) 1 (1) 4 (16) 3 (12) 16 (20) 12 (15) 0.018 0.003
G. vaginalis 71 (97) 6 (8) 24 (96) 10 (40) 79 (100) 69 (87) 0.19 <0.0001
M. hominis 11 (15) 3 (4) 7 (28) 4 (16) 50 (63) 46 (58) <0.0001 <0.0001
U. parvum 37 (51) 18 (25) 10 (40) 5 (20) 40 (51) 22 (28) 0.99 0.64
U. urealyticum 7 (10) 4 (5) 4 (16) 2 (8) 14 (18) 11 (14) 0.15 0.08
F. magna 30 (41) 30 (41) 17 (68) 17 (68) 50 (63) 50 (63) 0.006 0.006
Prevotella spp. 70 (96) 3 (4) 24 (96) 12 (48) 77 (97) 75 (95) 0.59 <0.0001
1Presence versus absence as determined by the target qPCR.
2Presence (≥ cut-off/ml) versus absence (< cut-off/ml) with cut-off determined by ROC curve analysis.
3 N indicates number of participants.
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Associations between different vaginal bacteria and BV
In the qualitative detection, all bacteria were significantly
associated with BV except for G. vaginalis, Prevotella spp.,
U. parvum, U. urealyticum, and L. iners. The strength of
association between BV and the bacteria under study in-
creased when odds-ratios were calculated using quantita-
tive detection, i.e., with cut-offs determined by ROC curve
analysis (Table 4). For A. vaginae, G. vaginalis, and BVAB
TM7, the OR could not be calculated for qualitative detec-
tion due to the presence of these bacteria in all women
with BV or absence in all women without BV (BVAB
TM7). The OR for L. iners was 0 in qualitative detec-
tion. In quantitative detection, the OR could not be
calculated for BVAB TM7 and Megasphaera type 2
due to their absence in women without BV or, in the case
of L. iners, presence in all women without BV. U. parvum,
U. urealyticum, and L. iners were not associated with BV.
With quantitative detection and cut-off determined by
ROC, all other bacteria were statistically associated with
BV (p < 0.01).
Best prediction of BV in a multivariate logistic regression
model
When analysing the seven bacteria with the largest
AUCs (marked with stars in Table 4) in a multivariate
logistic regression model, only Prevotella spp. and A. va-
ginae remained associated with BV, with p-values of
0.0095 and 0.03 and odds ratios of 4.4 and 1.9, respect-
ively (Table 5), after adjusting for other bacteria.
Vaginal bacterial communities in women with and
without BV
The vaginal bacterial community composition as shown
by a clustering tree attached to a heat-map of nor-
malised values of 16S rRNA gene copies was diverse and
heterogeneous in women with BV. L. iners was the main
species detected in women without BV (Figure 1). Among
women with BV, three clusters were dominated by single
taxa, i.e., Prevotella spp., BVAB1, and G. vaginalis; one
cluster was dominated by G. vaginalis/Prevotella spp. while
another cluster had BVAB1/G. vaginalis (Figure 1). The
remaining BV clusters contained multiple bacterial species.
Among the studied bacteria, L. iners was the best repre-
sented species among women without BV, while Prevotella
spp. and G. vaginalis were present in higher proportions
than the rest of bacteria were in women with Nugent III.
Co-occurrence of bacterial taxa was investigated by
calculating Spearman correlation coefficients (Figure 2,
see Additional file 2: Table S2 for a tabulation of the co-
efficients). The most significant cluster of correlations
Table 4 Odds-ratios (OR) and 95% confidence intervals (CI) (Fisher’s exact test) for BV
Species Qualitative detection Quantitative detection
Observed OR 95% CI p-value Observed OR 95% CI p-value
Atopobium vaginae ∞ 6-∞ < 0.0001 209 50-985 <0.0001
Sneathia sanguinegens 19 8-48 < 0.0001 72 16-634 < 0.0001
Leptotrichia amnionii 9 4-21 < 0.0001 140 30-1233 < 0.0001
BVAB 1 4 2-9 < 0.0001 16 6-56 < 0.0001
BVAB 2 40 14-120 < 0.0001 245 49-2191 < 0.0001
BVAB 3 12 5-30 < 0.0001 22 8-67 < 0.0001
BVAB-TM7 ∞ 9-∞ < 0.0001 ∞ 9-∞ < 0.0001
Megasphaera type 1 9 4-21 < 0.0001 307 43-12480 < 0.0001
Megasphaera type 2 6 2-22 0.0002 ∞ 7-∞ < 0.0001
Eggerthella-like bacterium 10 3-43 < 0.0001 85 23-453 < 0.0001
Mobiluncus curtisii 24 4-1025 < 0.0001 24 4-1025 < 0.0001
Mobiluncus mulieris 3 1-13 0.019 13 2-559 0.002
Gardnerella vaginalis ∞ 0.2-∞ 0.229 77 24-263 < 0.0001
Lactobacillus iners 0 0-2 0.121 ND ND ND
Mycoplasma hominis 10 4-23 < 0.0001 33 9-171 < 0.0001
Ureaplasma parvum 1 0.5-2 >0.9999 1 0.5-3 0.7
Ureaplasma urealyticum 2 0.7-6 0.1651 3 0.7-13 0.104
Finegoldia magna 2 1-5 0.0091 2 1-5 0.0091
Prevotella spp. 2 0.2-20 0.671 437 82-2779 < 0.0001
Nugent grade I (73 women) compared to grade III (79 women). Intermediate flora not included.
Detection of each bacterial species is after qualitative or quantitative detection with cut-off determined by ROC curve analysis.
ND indicates not determined.
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above 0.5 was found between BVAB2 and A. vaginae,
S. sanguinegens, L. amnionii, BVAB3, Megasphaera
type 1, and Eggerthella. Strong correlations were also ob-
served for L. amnionii with BVAB2 and 3, Megasphaera
type 1, and Eggerthella. Significant interactions were also
found for G. vaginalis with A. vaginae and for M. hominis
with S. sanguinegens and BVAB3. Negative correlations
were found primarily for L. iners, which had correlations
below −0.5 with A. vaginae, Prevotella spp., BVAB2, and
G. vaginalis.
Discussion
We found a high prevalence of BV in women from
Greenland, with 45% of the women scoring positive for
BV as determined by Nugent score. These figures are





































































































































Figure 1 Vaginal bacterial communities. Heat-map constructed by normalising the number of 16S rRNA gene copies/ml UTM for vaginal
bacteria in 177 women from Greenland with or without BV. Nugent scores are shown in the vertical column. The scale bar represents the
Euclidean distance, corresponds to 50,000 and is calculated after Pythagorean metric. The colour key shows colour code and corresponds to
normalised geq/ml UTM for each bacterium. The vertical red line indicates the level that was chosen for defining the clusters.
Table 5 Adjusted odds ratios with 95% confidence
intervals and p-values in a multivariate logistic
regression analysis
Species Logistic regression model
Adjusted OR 95% CI p-value
Atopobium vaginae 1.9 1.1-3.6 0.03
Leptotrichia amnionii 1.1 0.6- 2.2 0.7
BVAB2 2.0 0.9-4.4 0.07
Megasphaera type 1 1.4 0.9-2.4 0.1
Eggerthella-like bacterium 1.1 0.6-2.0 0.6
Gardnerella vaginalis 1.6 0.7- 3.9 0.2
Prevotella spp. 4.4 1.4-13.5 0.0095
The seven bacterial species were selected by ROC curve analysis with an area
under the curve >85%.
Data are log10 of 16S rRNA gene copies plus one and outcome is BV
compared with normal flora as determined by Nugent’s score.
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in 1991 [18] and comparable with the prevalence of
BV in African women [31]. STIs are highly prevalent
in Greenland, with chlamydia rates above 5,000/
100,000 inhabitants. We also found N. gonorrhoeae in
1%, C. trachomatis in 7%, and M. genitalium in 12%
of women tested, but T. vaginalis in only one woman
(0.5%). BV has been associated with C. trachomatis
[32] and N. gonorrhoeae infections [33-35], but we did
not find a statistically significant association between
any of the STIs and BV.
In contrast to other studies [36,37], no difference in
age between women with and without BV could be
found. An association between the lifetime number of
sexual partners and/or a recent new partner has been
found in several studies [14]; however, we did not con-
firm this association in the present study. Whether this
outcome can be explained by the high number of male
partners reported by the women in the present study is
not clear. The women in this study reported a median of
12.5 partners (Table 1), much higher than the median of
four partners reported by women in the UK National
Survey of Sexual Attitudes and Lifestyles (NATSAL-
2000) [38]. Thus, it is possible that the effect of the
number of partners was already saturated in the current
study’s population.
L. iners was detected by PCR in every participant with
normal flora at a median concentration as high as 3 ×
106 16S rRNA copies/ml UTM, a value higher than in
women with BV (median 8 × 105 16S rRNA copies/ml).
This finding is in accordance with other studies that sug-
gest L. iners is present in the majority of women regardless
of BV status [27]. Unfortunately, our DNA extraction
method did not allow for reproducible quantitative detec-
tion of other Lactobacillus spp., and the amount of the
original specimen did not allow for a repeated extraction.
The incomplete lysis of Lactobacillus spp. other than
L. iners was confirmed in an experiment comparing
the Chelex extraction used in this study with a modi-
fied QIAamp extraction protocol that included a pre-
incubation step with lysozyme on clinical specimens col-
lected independently from the present study. L. iners was
detected with good agreement between the two methods,
but 11 of 12 L. gasseri positive specimens showed false
negatives after Chelex extraction. Therefore, only L. iners
qPCR was performed on the samples in this study, and








































































































































Figure 2 Co-occurrence of bacterial species. Hierarchically clustered Spearman correlation coefficients between bacterial species. Correlation
values range from −0.65 to 1. Diagonal elements have a correlation of 1. Several bacteria associated with BV occur together. A tabulation of the
coefficients is available in (Additional file 2: Table S2).
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community groups, as previously described by Ravel
et al. [10].
In the present study, we showed that PCR may be a
useful tool in diagnosing BV. However, we found that
most of the BV-associated bacteria were also present in
women without BV, and therefore, qualitative detection
could not be used for diagnostic purposes. Consequently,
we used quantitative data obtained by applying ROC
curve analysis to determine the optimal cut-off level for
diagnostic purposes. It was found that seven species (A. va-
ginae, Prevotella spp., G. vaginalis, BVAB2, Eggerthella-like
bacterium, L. amnionii, and Megasphaera type 1) showed
promising diagnostic potential in that they had areas under
the ROC curve of > 85%, which suggests good discrimin-
atory power for BV prediction. Some of these species, i.e.,
A. vaginae, G. vaginalis, BVAB2, and Megasphaera type 1,
have been previously reported to be useful predictors for
BV [39,40]. The same set of qPCRs applied on vaginal
swabs from a Swedish population revealed the same seven
bacterial species as the best predictors for BV [41]. How-
ever, the thresholds for bacterial load in our study were
not identical to the study by Shipitsyna. This discrep-
ancy can be explained to some extent by the use of dif-
ferent methods for diagnosing BV (Nugent in the present
study in contrast to Amsel’s criteria in the study by
Shipitsyna), different DNA extraction methods (simple
lysis by boiling with Chelex resin versus a Qiagen DNeasy
Blood and Tissue Kit), and different methods of collecting
the samples (self-collected with flocked swabs in UTM ver-
sus physician collected samples with 10 μl plastic loops).
For most species, the threshold values in the present study
were 10- to 50-fold higher than those found in the Swedish
patients. However, some notable differences were observed;
BVAB3 had a 7-fold lower threshold in the women from
Greenland, while Eggerthella-like bacterium, BVAB1, and
Mobiluncus mulieris had thresholds approximately 2000-
fold higher in the women from Greenland, suggesting a
much higher level of carriage in women without BV as de-
termined by Nugent score. Whether these differences re-
flect true population differences or can be traced back to
technical differences remains unclear, but these results em-
phasise that relevant thresholds should be determined in
the population under study using standardised techniques.
The vaginal swab specimens were kept in Copan UTM
transport medium and refrigerated for up to 5 days before
shipment at ambient temperature, typically reaching the la-
boratory within 1 to 2 days. It cannot be excluded that
some growth or even degradation of microbial DNA may
have occurred during this time and led to the differences
in threshold values. However, the UTM medium contains
colistin, vancomycin, and amphotericin B, which restrict
the growth of Gram-positive bacteria, Gram-negative bac-
teria, and fungi, respectively, and because many of the
BV-associated bacteria have been excessively difficult
to cultivate, distortion of the microflora during transport is
most likely insignificant. Furthermore, in another study
(Datcu et al., accepted for publication), the bacterial load of
eight selected BV associated bacteria in first void urine
samples transported in GeneLock (a transport medium
designed to stabilise DNA and RNA) was shown to correl-
ate significantly with the bacterial load in the correspond-
ing vaginal swab specimens described in the present study,
suggesting that degradation of DNA in UTM during trans-
port is not of major importance.
Using quantitative detection and Nugent scoring as
the gold standard for BV, the combination of Prevotella
spp. and A. vaginae had a high specificity at 99%, but the
sensitivity decreased to 90%. When considering Prevotella
spp. or A. vaginae, the specificity decreased to 89% while
the sensitivity increased to 100%. Thus, by combining
“Prevotella spp. and/or A. vaginae,” it is possible to select
either an almost perfect specificity or an optimal sensitivity.
Consequently, these 2 real-time PCRs together can diag-
nose BV with extremely high accuracy.
The average number of non-Lactobacillus species rep-
resented in the samples, i.e., the diversity, increased with
progression from the normal microbiome (average 6.2
species with a range of 3–10) to BV (average 11.7 spe-
cies, range 5–16). Fredricks et al. [27] found an average
of only 3.6 species (range 0–14) detected in women
without BV, a difference that could be explained partly
because PCR assays for M. hominis, U. urealyticum, and
U. parvum were not performed and one PCR assay was
used for both Leptotrichia/Sneathia spp. Compared with
data presented for the vaginal flora of US women [27],
the flora in women from Greenland was different largely
in the detection of nearly all evaluated species in a mark-
edly higher proportion of the women from Greenland
with normal microbiota as determined by Nugent’s cri-
teria. However, Zozaya-Hinchliffe [29] found an average
of 9.5 non-Lactobacillus species for women with normal
vaginal flora in samples from US women who attended
an STD clinic. Whether this increase reflects differences
in the detection limit of the assays or a higher rate of
colonisation with these bacteria due to either behavioral
or genetic differences remains to be established. The
women included in the present study had a high number
of lifetime sexual partners, and a previous study by
Fethers and colleagues [42] showed that increasing fre-
quency of six of the eight BV candidate organisms included
in the study (Megasphaera type 1, BVAB 2, BVAB 3,
Sneathia spp., Leptotrichia spp., and G. vaginalis) corre-
lated with increasing sexual exposure, suggesting potential
sexual transmission of these bacteria.
Using quantitative detection with cut-offs determined
by ROC analysis, all non-Lactobacillus species except
U. parvum and U. urealyticum were significantly asso-
ciated with BV in univariate analysis. Prevotella spp.
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and A. vaginae remained significantly associated with BV
in a multivariate logistic regression model performed on
the seven species selected by their AUC values of > 85% in
ROC analysis.
The women with Nugent grade III could be further
divided into distinct sub-types of BV flora dominated
by different bacterial species, such as Prevotella spp.,
G. vaginalis, or BVAB 1, or by combinations of species,
dominated by G. vaginalis/Prevotella spp. and BVAB1/
G. vaginalis. This finding is in accordance to some ex-
tent with other studies using 454 pyrosequencing of
amplicons generated with universal 16S primers [43], al-
though the clusters identified in the present study were
somewhat different, particularly with Sneathia/Leptotrichia
spp.-dominated clusters being less prominent. Whether
this difference reflects methodological or true population-
dependent differences is not clear. The sub-clustering
clearly suggests that the diagnosis of BV may be a simpli-
fied grouping of several conditions and refined diagnostic
methods may prove useful in both stratifying the treatment
of the condition and targeting treatment to prevent com-
plications in relevant subgroups.
Prevotella spp. have been found in the majority of pa-
tients in culture-based surveys of vaginal microbiomes
[44] and are one of the most common operational taxo-
nomic units (OTUs) present in recent molecular studies
[45]. Prevotella spp. and BVAB1 have been reported to
dominate in single taxon clusters of BV communities
[43]. Bacteria that dominate in pairs may act synergistically
or may have a symbiotic or even mutual relationship; this
may be the case for G. vaginalis with Prevotella spp.; it has
been shown that amino acids produced during G. vaginalis
growth may promote the growth of P. bivia. Conversely,
the growth of G. vaginalis becomes limited by a shortage
in available ammonia, which can be provided by P. bivia
[46]. However, we and others have found that G. vaginalis
dominated in BV clusters by itself, in the absence of high
concentrations of Prevotella spp., suggesting that there
may be other mechanisms not clearly understood to sus-
tain the growth of this bacterium.
Correlations between species were also found. Most
notably, BVAB2 had strong correlations with A. vaginae,
S. sanguinegens, L. amnionii, BVAB3, Megasphaera type 1,
and Eggerthella-like bacteria. This is in agreement with
findings using 454 pyrosequencing [43], although this
study found positive correlations with some Prevotella spe-
cies but negative correlations with others. However, the
less discriminative approach chosen in the present study
can easily explain this discrepancy.
The lack of specific detection of other Lactobacillus
spp. reported to be part of the normal microbiome
of the human vagina, such as Lactobacillus crispatus,
Lactobacillus jensenii, and Lactobacillus gasseri, is a poten-
tial limitation of the study presented here. However, as
these species are mainly associated with healthy vaginal
flora, the conclusions reached for women with BV should
not be affected. Although using specific quantitative PCRs
limits the study to selected species, a major strength of this
approach is that individually performed assays are less sus-
ceptible to amplification bias. In broad-range 16S PCR, dif-
ferences in the amplification efficiency resulting from
imperfect sequence matches of the primers with some spe-
cies as well as competitive amplification in which the most
abundant species tend to dominate may skew the species
distribution. Future research should determine which sub-
types of BV communities confer significant health risks to
women and aim to stratify treatment to avoid the common
recurrence of BV.
Conclusions
In summary, our study confirmed a high prevalence of
BV in women from Greenland. A. vaginae and G. vaginalis
were present in all patients with BV by qualitative detec-
tion and also in a high proportion of women with normal
microbiota as determined by Nugent’s criteria. Using cut-
offs determined by ROC curve analysis and a combination
of Prevotella spp. and/or A. vaginae PCR, we were able to
diagnose BV with high accuracy. Prevotella spp. had the
highest odds-ratio and adjusted odds-ratio for BV in uni-
variate analysis. In multivariate logistic analysis, Prevotella
spp. and A. vaginae were both independently associated
with BV. Different clusters of BV communities could be
identified in women from Greenland, some of which were
dominated by one or two bacterial species, suggesting
metabolic co-dependencies. Further molecular studies are
needed to establish the clinical consequences of the differ-
ent BV profiles.
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